| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | $6.76M | $5.45M | $15.34M |
| R&D | – | – | – | – | – |
| SG&A | $3.61M | $3.66M | $3.46M | $3.77M | $3.94M |
| Operating Income | -$9.29M | $10.54M | -$6.76M | – | – |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$7.50M | $11.25M | -$6.58M | -$4.93M | -$15.24M |
| EPS (basic) | -0.0600 | 0.0900 | -0.0500 | -0.0400 | -0.1400 |
| EPS (diluted) | -0.0600 | 0.0900 | -0.0500 | -0.0400 | -0.1400 |
| Shares (diluted) | $125.16M | $125.61M | $120.47M | $118.01M | $110.26M |